Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

The Correlation Between Alcohol Use Disorder and Tuberculosis

  • Yeon Jeong Oh (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Xianglan Xuan (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Minju Jung (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Sohyeong Kim (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Yujin Park (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Hyun Jun Woo (Department of Clinical Laboratory Science, College of Health and Biotechnology, Semyung University) ;
  • Jang-Eun Cho (Department of Biomedical Laboratory Science, Daegu Health College) ;
  • Sunghyun Kim (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
  • Received : 2024.10.04
  • Accepted : 2024.10.26
  • Published : 2024.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis complex. Along with acquired immunodeficiency syndrome (AIDS) and malaria, TB is one of the three major diseases on which the World Health Organization focuses for intensive management. Furthermore, TB is the second most infectious disease following coronavirus disease 2019, excluding human immunodeficiency virus (HIV), and AIDS. The main risk factors for TB include malnutrition, HIV infection, smoking, diabetes, and alcohol use disorder. Several studies have reported a direct correlation between alcoholism and pulmonary TB. This study aimed to review the impact of alcohol use disorder on TB by connecting various epidemiological data and the existing literature on the correlation between alcohol use disorder and TB. Furthermore, it emphasizes the need for early diagnosis and prevention as well as prompt treatment of TB in patients with alcohol addiction and alcohol use disorder for the effective management of TB.

Keywords

Acknowledgement

This study was supported by the Brain Busan 21 Plus project.

References

  1. World Health Organization (WHO). Global tuberculosis report 2022. WHO; 2022. p. 31.
  2. World Health Organization (WHO). Compendium of TB/COVID-19 studies [Internet]. WHO; c2022 [cited 2024 Aug20]. Available from: https://www.who.int/teams/globaltuberculosis-programme/covid-19/compendium
  3. Korea Disease Control and Prevention Agency (KDCA). Annual report on the notified tuberculosis in Korea, 2020. KDCA; 2020.
  4. Min J, Kim HW, Ko Y, Oh JY, Kang JY, Lee J, et al. Tuberculosis surveillance and monitoring under the national public private mix tuberculosis control project in South Korea 2016-2017. Tuberc Respir Dis (Seoul). 2020;83:218-27. https://doi.org/10.4046/trd.2020.0016
  5. Gordon SV, Parish T. Microbe profile: mycobacterium tuberculosis: humanity's deadly microbial foe. Microbiology (Reading). 2018;164:437-9. https://doi.org/10.1099/mic.0.000601
  6. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1969;99:109-11.
  7. Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. 2012;12:581-91. https://doi.org/10.1038/nri3259
  8. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111-5. https://doi.org/10.1093/cid/ciw778
  9. World Health Organization (WHO). Global tuberculosis report 2020. WHO; 2020.
  10. Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J. 2017;50:1700216. https://doi.org/10.1183/13993003.00216-2017
  11. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450. https://doi.org/10.1186/1471-2458-9-450
  12. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health. 2008;8:289. https://doi.org/10.1186/1471-2458-8-289
  13. Boé DM, Vandivier RW, Burnham EL, Moss M. Alcohol abuse and pulmonary disease. J Leukoc Biol. 2009;86:1097-104. https://doi.org/10.1189/jlb.0209087
  14. Molina PE, Sulzer JK, Whitaker AM. Alcohol abuse and the injured host: dysregulation of counterregulatory mechanisms review. Shock. 2013;39:240-9. https://doi.org/10.1097/SHK.0b013e318285b86d
  15. Szabo G, Saha B. Alcohol's effect on host defense. Alcohol Res. 2015;37:159-70. https://doi.org/10.35946/arcr.v37.2.01
  16. Leusden RP, Stark K. [Infectious diseases in intravenous drug abuse patients]. Z Arztl Fortbild (Jena). 1992;86:709-16. German.
  17. World Health Organization (WHO). World health statistics 2018: monitoring health for the SDGs, sustainable development goals. WHO; 2018.
  18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5TM. 5th ed. American Psychiatric Publishing; 2013.
  19. World Health Organization (WHO). World health statistics 2019: monitoring health for the SDGs, sustainable development goals. WHO; 2019.
  20. Institute for Health Metrics and Evaluation (IHME). Global burden of disease (GBD) study 2017 [Internet]. IHME; c2017 [cited 2024 Aug 20]. Available from: https://ghdx.healthdata.org/gbd-2017
  21. Rush B. An inquiry into the effects of ardent spirits upon the human body and mind: with an account of the means of preventing, and of the remedies for curing them. 4th ed. Archibald Bartram; 1805.
  22. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis. 1982;125(3 Pt 2):8-15.
  23. Flynn JL, Bloom BR. Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis. Ann N Y Acad Sci. 1996;795:137-46. https://doi.org/10.1111/j.1749-6632.1996.tb52662.x
  24. Wigger GW, Bouton TC, Jacobson KR, Auld SC, Yeligar SM, Staitieh BS. The impact of alcohol use disorder on tuberculosis: a review of the epidemiology and potential immunologic mechanisms. Front Immunol. 2022;13:864817. https://doi.org/10.3389/fimmu.2022.864817
  25. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system--a review. Alcohol Clin Exp Res. 1998;22:1927-42.
  26. Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc. 2005;2:428-32. https://doi.org/10.1513/pats.200507-065JS
  27. Szabo G. Alcohol's contribution to compromised immunity. Alcohol Health Res World. 1997;21:30-41.
  28. Zhang P, Bagby GJ, Happel KI, Summer WR, Nelson S. Pulmonary host defenses and alcohol. Front Biosci. 2002;7:d1314-30. https://doi.org/10.2741/A842
  29. Pavia CS, La Mothe M, Kavanagh M. Influence of alcohol on antimicrobial immunity. Biomed Pharmacother. 2004;58:84-9. https://doi.org/10.1016/j.biopha.2003.12.005
  30. Specter S. Drugs of abuse and infectious diseases. J Fla Med Assoc. 1994;81:485-7.
  31. Vander Top EA, Wyatt TA, Gentry-Nielsen MJ. Smoke exposure exacerbates an ethanol-induced defect in mucociliary clearance of Streptococcus pneumoniae. Alcohol Clin Exp Res. 2005;29:882-7. https://doi.org/10.1097/01.ALC.0000164364.35682.86
  32. Dannenberg AM Jr. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis. 1989;11 Suppl 2:S369-78. https://doi.org/10.1093/clinids/11.Supplement_2.S369
  33. Castro A, Lefkowitz DL, Lefkowitz SS. The effects of alcohol on murine macrophage function. Life Sci. 1993;52:1585-93. https://doi.org/10.1016/0024-3205(93)90059-C
  34. Dorio RJ, Forman HJ. Ethanol inhibition of signal transduction in superoxide production by rat alveolar macrophages. A proposed mechanism for ethanol related pneumonia. Ann Clin Lab Sci. 1988;18:190-4.
  35. Rimland D, Hand WL. The effect of ethanol on adherence and phagocytosis by rabbit alveolar macrophages. J Lab Clin Med. 1980;95:918-26.
  36. Rimland D. Mechanisms of ethanol-induced defects of alveolar macrophage function. Alcohol Clin Exp Res. 1984;8:73-6.
  37. Szabo G, Mandrekar P, Catalano D. Inhibition of superantigen-induced T cell proliferation and monocyte IL-1 beta, TNF-alpha, and IL-6 production by acute ethanol treatment. J Leukoc Biol. 1995;58:342-50. https://doi.org/10.1002/jlb.58.3.342
  38. Chen L, Sun R, Lei C, Xu Z, Song Y, Deng Z. Alcoholmediated susceptibility to lung fibrosis is associated with group 2 innate lymphoid cells in mice. Front Immunol. 2023;14:1178498. https://doi.org/10.3389/fimmu.2023.1178498
  39. Fiske CT, Hamilton CD, Stout JE. Alcohol use and clinical manifestations of tuberculosis. J Infect. 2009;58:395-401. https://doi.org/10.1016/j.jinf.2009.02.015
  40. Caroline MK, Simon M, Njani E. Co-occurrence between alcohol use and tuberculosis among patients in Othaya Level 4 Hospital. AJADA. 2022;8:14-29.
  41. World Health Organization (WHO). Global tuberculosis report 2021. WHO; 2021.
  42. Alcohol-related mental disorders have increased by an average of 4.3% per year over the past five years [Internet]. The minjok medicine news: c2012 [cited 2024 Aug 20]. Available from: https://mjmedi.com/news/articleView.html?idxno=23812
  43. Jeong J, Yun S, Chae S, Choe J. Current status of alcohol and drug addiction and policy responses. Sejong: Korea Institute for Health and Social Affairs; 2014 Dec. Report No.: 2014-24-1.
  44. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16. https://doi.org/10.1001/archinte.164.20.2206
  45. Lewis JG, Chamberlain DA. Alcohol consumption and smoking habits in male patients with pulmonary tuberculosis. Br J Prev Soc Med. 1963;17:149-52.
  46. Altet-Gômez MN, Alcaide J, Godoy P, Romero MA, Hernández del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis. 2005;9:430-6.
  47. Francisco J, Oliveira O, Felgueiras Ó, Gaio AR, Duarte R. How much is too much alcohol in tuberculosis? Eur Respir J. 2017;49:1601468. https://doi.org/10.1183/13993003.01468-2016
  48. Thomas BE, Thiruvengadam K, Rani S, Kadam D, Ovung S, Sivakumar S, et al.; CTRIUMPH-RePORT India Study. Smoking, alcohol use disorder and tuberculosis treatment outcomes: a dual co-morbidity burden that cannot be ignored. PLoS One. 2019;14:e0220507. https://doi.org/10.1371/journal.pone.0220507
  49. Bhatt M, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J Cancer. 2012;1:36-42. https://doi.org/10.4103/2278-330X.96507
  50. Pedrazzoli D, Abubakar I, Potts H, Hunter PR, Kruijshaar ME, Kon OM, et al. Risk factors for the misdiagnosis of tuberculosis in the UK, 2001-2011. Eur Respir J. 2015;46:564-7. https://doi.org/10.1183/09031936.00227914
  51. Høyer G, Nilssen O, Brenn T, Schirmer H. The Svalbard study 1988-89: a unique setting for validation of self-reported alcohol consumption. Addiction. 1995;90:539-44. https://doi.org/10.1111/j.1360-0443.1995.tb02188.x
  52. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375:1814-29. https://doi.org/10.1016/S0140-6736(10)60483-7
  53. Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, et al. Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, South India. Indian J Tuberc. 2007;54:130-5.
  54. de Albuquerque MFPM, Ximenes RA, Lucena-Silva N, de Souza WV, Dantas AT, Dantas OM, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saude Publica. 2007;23:1573-82. https://doi.org/10.1590/S0102-311X2007000700008
  55. Myers B, Bouton TC, Ragan EJ, White LF, McIlleron H, Theron D, et al. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect Dis. 2018;18:488. https://doi.org/10.1186/s12879-018-3396-y
  56. Silva MR, Pereira JC, Costa RR, Dias JA, Guimarães MDC, Leite ICG. Drug addiction and alcoholism as predictors for tuberculosis treatment default in Brazil: a prospective cohort study. Epidemiol Infect. 2017;145:3516-24. https://doi.org/10.1017/S0950268817002631
  57. Ko Y, Min J, Kim HW, Koo HK, Oh JY, Jeong YJ, et al. Time delays and risk factors in the management of patients with active pulmonary tuberculosis: nationwide cohort study. Sci Rep. 2022;12:11355. https://doi.org/10.1038/s41598-022-15264-w
  58. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al.; for WHO's Global TB Programme. WHO's new end TB strategy. Lancet. 2015;385:1799-801. https://doi.org/10.1016/S0140-6736(15)60570-0
  59. Salami AK, Oluboyo PO. Management outcome of pulmonary tuberculosis: a nine year review in Ilorin. West Afr J Med. 2003;22:114-9.
  60. Jastrzębska I, Zwolak A, Szczyrek M, Wawryniuk A, Skrzydło-Radomańska B, Daniluk J. Biomarkers of alcohol misuse: recent advances and future prospects. Prz Gastroenterol. 2016;11:78-89. https://doi.org/10.5114/pg.2016.60252
  61. Ferguson LB, Mayfield RD, Messing RO. RNA biomarkers for alcohol use disorder. Front Mol Neurosci. 2022;15:1032362. https://doi.org/10.3389/fnmol.2022.1032362